Postmortem redistribution of two antipsychotic drugs, haloperidol and thioridazine, in the rat

被引:8
|
作者
Castaing, Nadege
Titier, Karine
Canal-Raffin, Mireille
Moore, Nicholas
Molimard, Mathieu
机构
[1] CHU Bordeaux, Lab Pharmacol Clin & Toxicol, F-33076 Bordeaux, France
[2] Univ Victor Segalen, Dept Pharmacol, F-33076 Bordeaux, France
关键词
D O I
10.1093/jat/30.7.419
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Antipsychotic drugs may be associated with arrhythmia, ventricular fibrillation, or torsades de pointes, which can result in sudden death. These drugs could therefore be found in postmortem toxicological analyses of autopsy specimens following unexplained sudden death. The drug concentrations in tissues and body fluids change between the death and postmortem specimens collection because of postmortem redistribution. For this reason, it is often difficult to interpret the postmortem analysis. The aim of this study was to investigate postmortem redistribution of the two cardiotoxic antipsychotic drugs, haloperidol and thioridazine, in order to interpret the postmortem analysis. We have chosen the rat as an animal model. The rats received 1 mg/kg of haloperidol and 5 mg/kg of thioridazine by intraperitoneal injection. They were sacrificed and left at room temperature for 2, 6, 12, 24, or 48 h, at which times blood and tissue samples were taken. The drug analyses in tissues and blood were done using a liquid chromatography-tandem mass spectrometry method. Our results show that there is a redistribution of the two drugs from the lung to the cardiac blood. The concentration of the antipsychotic drugs in the lung decreased rapidly, whereas in the cardiac blood, this concentration increased within the first 2 h postmortem. By 48 h after death, the concentrations of the antipsychotic drugs were about twice as high as the initial concentrations in the cardiac blood. For the lungs, a decrease of 50% was observed between 0 and 48 h. Only myocardium and muscle concentrations did not change with the postmortem delay.
引用
收藏
页码:419 / 425
页数:7
相关论文
共 50 条
  • [41] Kombination zweier DepotantipsychotikaCombination of two depot antipsychotic drugs
    K. Yazdi
    J. Rosenleitner
    B. Pischinger
    [J]. Der Nervenarzt, 2014, 85 : 870 - 871
  • [42] Atypical antipsychotic drugs Two points of clinical interest
    Krishnadas, Rajeev
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2011, 342
  • [43] METABOLISM OF PIPERIDINE-TYPE PHENOTHIAZINE ANTIPSYCHOTIC AGENTS .4. THIORIDAZINE IN DOG, MAN AND RAT
    LIN, G
    HAWES, EM
    MCKAY, G
    KORCHINSKI, ED
    MIDHA, KK
    [J]. XENOBIOTICA, 1993, 23 (10) : 1059 - 1074
  • [44] Letters to the Editor - Combination of two depot antipsychotic drugs
    Yazdi, K.
    Rosenleitner, J.
    Pischinger, B.
    [J]. NERVENARZT, 2014, 85 (07): : 870 - 871
  • [45] Monte Carlo optimization method based QSAR modeling of postmortem redistribution of structurally diverse drugs
    Antovic, Aleksandra R.
    Karadzic, Radovan
    Veselinovic, Aleksandar M.
    [J]. NEW JOURNAL OF CHEMISTRY, 2022, 46 (30) : 14731 - 14737
  • [46] The effects of antipsychotic drugs on dopaminergic and serotonergic activity in the rat hypothalamus
    Daskas, S
    Antoniou, K
    Drossopoulou, G
    Rimikis, M
    Papadopoulou-Daifoti, Z
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S325 - S325
  • [48] Antipsychotic drugs differentially modulate apolipoprotein D in rat brain
    Khan, MM
    Parikh, VV
    Mahadik, SP
    [J]. JOURNAL OF NEUROCHEMISTRY, 2003, 86 (05) : 1089 - 1100
  • [49] A rat model for studying metabolic adverse effects of antipsychotic drugs
    de Beaurepaire, R.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 31 - 31
  • [50] Antipsychotic drugs regulate neurotrophic factor expression in the rat brain
    Riva, MA
    Molteni, R
    Zolin, K
    Massironi, A
    Tascedda, F
    Racagni, G
    [J]. SCHIZOPHRENIA RESEARCH, 1999, 36 (1-3) : 118 - 119